PTPRC and neoplasm: The enrichment of CD45 and CD45RO around the tumor-immune boundaries (Fig. 5i), which was also described in the original paper, indicated that they may function during the battle of immune tissue against the tumor tissue via multiple apoptosis-associated immune signaling pathways.